In fact, there is a well-documented counter-regulatory reduction in metabolic rate in both humans (31, 32) and rodents (30, 33) treated with GLP-1R agonists for extended periods due to the reduction food intake
In a PCPA-induced insomnia mouse model, DSIP-CBBBP outperformed DSIP alonemore effectively restoring neurotransmitter balance, reducing wakefulness, easing anxiety and depression-like behaviors, improving reward response, and repairing brain tissue damage
Making sure you're losing fat mass effectively while preserving your lean body mass (LBM) is a vital step for better overall health and to achieve your weight loss goals in the short and long term
In 2014, Liraglutide became the first GLP-1RA medication to be introduced to the US market for treatment of obesity and weight management (12)
Each vial is supplied in lyophilized form for laboratory research use only